Skip to content

Author

Barbara Corti

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors

Background/Aim: Advanced melanoma treatment remains debated, particularly in patients with B-Raf proto-oncogene serine/threonine kinase (BRAF) V600 mutations eligible for both immune checkpoint inhibitors (ICI) and BRAF/MEK inhibitors. Additional biomarkers are needed to improve treatment selection. Mutations of the te...

P. Marchese, Irene Zannini, D. de Biase et al. · 0 citations
Open access Jul 2026

Thin Nevus-Associated Melanoma: Beyond MIA Score Risk Stratification

Simple Summary Nevus-associated melanoma, a melanoma arising in association with a pre-existing melanocytic nevus, accounts for approximately one-quarter of all cutaneous melanomas and is usually diagnosed at an early stage. Although thin nevus-associated melanomas generally have an excellent prognosis, a small proport...

Federico Venturi, Maria Luisa Orlando, Barbara Corti et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.